The concomitant use of oxycodone HCl with all cytochrome P450 3A4 inhibitors may possibly bring about a rise in oxycodone plasma concentrations, which could increase or prolong adverse reactions and may result in most likely deadly respiratory melancholy. Moreover, discontinuation of the concomitantly utilized cytochrome P450 3A4 inducer may well e